Health care's biggest day since the tariff bounce

The Health Care Select Sector SPDR (XLV) rose 3.5% on August 19 to a record close of 175.68 — its largest one-day gain since April 9, 2025, the tariff-pause bounce, and its second straight record close, the third in August. The driver was one trial readout: the Moderna–Merck personalized mRNA melanoma vaccine met its late-stage goals. Merck gained 12.6%, the biggest single day in our 17-year record for the stock, closing at a fresh 52-week high of $152.20 at a market value near $380 billion; BioNTech rose 22.0% and Moderna 177%.

A sector index moving 3.5% on a single company’s trial result is rare — XLV is cap-weighted and diversified across 60-plus names, so a move that size required the entire complex to reprice. The reading is descriptive: health care had lagged the market for most of the past two years, and one readout does not settle whether this is the start of a durable rotation.